# Enablers and Barriers to Hydroxyurea Use for Sickle Cell Disease Jamaica

> **NCT05909657** · — · UNKNOWN · sponsor: **The University of The West Indies** · enrollment: 450 (estimated)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **OTHER:** questionnaires (surveys)

## Key facts

- **NCT ID:** NCT05909657
- **Lead sponsor:** The University of The West Indies
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-01
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2023-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05909657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05909657, "Enablers and Barriers to Hydroxyurea Use for Sickle Cell Disease Jamaica". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05909657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*